Understanding Patient Engagement Trends in TBI Clinical Research

Not yet recruiting

• Conditions: TBI

• Registration Number: NCT06288698
• Lead Sponsor: Power Life Sciences Inc.

Brief Summary

Clinical trials, specifically focused on TBI, are crucial in assessing the safety and efficacy of new treatments. These trials serve as fundamental instruments in determining whether emerging medications outperform standard therapies, providing compelling evidence to support wider implementation.

The main goal is to thoroughly scrutinize trial completion rates and voluntary withdrawals among this particular group of patients.

Detailed Description

Not available

Study Timeline

• Status Verified: 2024-02
• Study First Submitted: 2024-02-23
• Study First Submitted QC: 2024-02-23
• Last Update Submitted: 2024-02-23
• Study First Posted: 2024-03-01
• Last Update Posted: 2024-03-01
• Study Start: 2025-03
• Primary Completion: 2026-03
• Study Completion: 2027-03

Recruitment & Eligibility

• Status: NOT_YET_RECRUITING
• Sex: All
• Target Recruitment: 500

Inclusion Criteria

• Ability to understand and the willingness to sign a written informed consent document
• Participant must be 18 years of age or older
• Confirmed diagnosis of TBI

Exclusion Criteria

• Enrolled in another research study
• Is pregnant, breastfeeding or expecting to conceive within the projected duration of the study
• Inability to provide written informed consent

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Number of TBI patients who decide to enroll in a clinical research	3 months
Rate of TBI patients who remain in clinical trial to trial completion	12 months

Trial Locations

Locations (1)

Power Life Sciences; 🇺🇸 San Francisco, California, United States